Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C
Int J Mol Sci. 2024; 25(15).
PMID: 39125729
PMC: 11311853.
DOI: 10.3390/ijms25158160.
Forero-Pena D, Carrion-Nessi F, Lopez-Perez M, Mora M, Amaya I, Gamardo A
Infect Dis Poverty. 2023; 12(1):33.
PMID: 37038195
PMC: 10084699.
DOI: 10.1186/s40249-023-01089-w.
Apostolou E, Rizwan M, Moustardas P, Sjogren P, Bertilson B, Bragee B
Front Immunol. 2022; 13:949787.
PMID: 36341457
PMC: 9630598.
DOI: 10.3389/fimmu.2022.949787.
Hayun M, Szwarcwort M, Rosenberg D, Sahar D, Ofran Y
J Cell Mol Med. 2021; 25(22):10778-10782.
PMID: 34651440
PMC: 8581312.
DOI: 10.1111/jcmm.16992.
Martinez L, Daniels-Wells T, Guo Y, Magpantay L, Candelaria P, Penichet M
Mol Cancer Ther. 2021; 20(9):1592-1602.
PMID: 34158342
PMC: 8419068.
DOI: 10.1158/1535-7163.MCT-21-0074.
Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
Hoffman T, Kolstad L, Lindahl J, Albinsson B, Bergqvist A, Ronnberg B
Viruses. 2021; 13(6).
PMID: 34073484
PMC: 8227055.
DOI: 10.3390/v13060993.
Epstein-Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity.
Nagata K, Hayashi K
Microorganisms. 2020; 8(12).
PMID: 33260824
PMC: 7760294.
DOI: 10.3390/microorganisms8121875.
False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.
Valota M, Thienemann F, Misselwitz B
BMJ Case Rep. 2019; 12(5).
PMID: 31079040
PMC: 6536262.
DOI: 10.1136/bcr-2018-228356.
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?.
Cavalcante P, Marcuzzo S, Franzi S, Galbardi B, Maggi L, Motta T
Oncotarget. 2017; 8(56):95432-95449.
PMID: 29221139
PMC: 5707033.
DOI: 10.18632/oncotarget.20731.
Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.
Epeldegui M, Martinez-Maza O
For Immunopathol Dis Therap. 2017; 6(1-2):79-90.
PMID: 28702272
PMC: 5502768.
DOI: 10.1615/ForumImmunDisTher.2016014177.
Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus.
Tabll A, Abbas A, El-Kafrawy S, Wahid A
World J Hepatol. 2015; 7(22):2369-83.
PMID: 26464752
PMC: 4598607.
DOI: 10.4254/wjh.v7.i22.2369.
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.
De Paschale M, Clerici P
World J Virol. 2013; 1(1):31-43.
PMID: 24175209
PMC: 3782265.
DOI: 10.5501/wjv.v1.i1.31.
Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.
Brisslert M, Rehnberg M, Bokarewa M
Immunology. 2013; 140(4):421-9.
PMID: 23844744
PMC: 3839646.
DOI: 10.1111/imm.12151.
Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection.
Getahun A, Smith M, Kogut I, van Dyk L, Cambier J
J Immunol. 2012; 189(6):2965-74.
PMID: 22904300
PMC: 3436999.
DOI: 10.4049/jimmunol.1201407.
Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG.
Maletzki C, Jahnke A, Ostwald C, Klar E, Prall F, Linnebacher M
PLoS One. 2012; 7(2):e32639.
PMID: 22393427
PMC: 3290587.
DOI: 10.1371/journal.pone.0032639.
Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses.
Sullivan M, Kaur K, Pauli N, Wilson P
F1000 Biol Rep. 2011; 3:17.
PMID: 21876728
PMC: 3155207.
DOI: 10.3410/B3-17.
The Sonoda-Tajima Cell Collection: a human genetics research resource with emphasis on South American indigenous populations.
Danjoh I, Saijo K, Hiroyama T, Nakamura Y
Genome Biol Evol. 2011; 3:272-83.
PMID: 21383383
PMC: 3070430.
DOI: 10.1093/gbe/evr014.
A novel method for making human monoclonal antibodies.
Fraussen J, Vrolix K, Martinez-Martinez P, Losen M, Meulemans E, De Baets M
J Autoimmun. 2010; 35(2):130-4.
PMID: 20732843
PMC: 7126289.
DOI: 10.1016/j.jaut.2010.05.001.
Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.
Magnusson M, Brisslert M, Zendjanchi K, Lindh M, Bokarewa M
Rheumatology (Oxford). 2010; 49(10):1911-9.
PMID: 20547657
PMC: 2936947.
DOI: 10.1093/rheumatology/keq159.
B cell characterization and reactivity analysis in multiple sclerosis.
Fraussen J, Vrolix K, Martinez-Martinez P, Losen M, De Baets M, Stinissen P
Autoimmun Rev. 2009; 8(8):654-8.
PMID: 19239929
PMC: 7185554.
DOI: 10.1016/j.autrev.2009.02.030.
